Adenosine signaling as a hub for the action of novel antidepressant strategies
Cell Chemical Biology · 2026
DOI: 10.1016/j.chembiol.2025.12.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Chemical Biology, 2026. Verfasst von Ana M Sebastião. Beteiligte Einrichtung: Instituto de Farmacologia e Neurociências, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal; Centro Cardiovascular da Univers…. Hauptthemen laut MEDLINE: Antidepressive Agents, Signal Transduction, Adenosine, Major Depressive Disorder. Die Arbeit nennt 10 Literaturangaben. Gefördert von: Foundation for Science and Technology, Precursory Research for Embryonic Science and Technology, COST.
Abstract (Originalsprache)
In a study recently published in Nature, Yue et al.1 provide a causal relationship between mitochondrial metabolism, adenosine receptor signaling, and the mechanism of action for novel antidepressants. Their findings identify adenosine as a key driver of rapid-acting antidepressant effects and as a therapeutic target for major depressive disorder.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Instituto de Farmacologia e Neurociências, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal; Centro Cardiovascular da Universidade de Lisboa, CCUL (CCUL@RISE), Faculdade de Medicina, Universidade…
Förderung
- Foundation for Science and Technology
- Precursory Research for Embryonic Science and Technology
- COST
Zitieren
APA
Sebastião, A. M. (2026). Adenosine signaling as a hub for the action of novel antidepressant strategies. Cell Chemical Biology. https://doi.org/10.1016/j.chembiol.2025.12.014
Vancouver
Sebastião AM. Adenosine signaling as a hub for the action of novel antidepressant strategies. Cell Chemical Biology. 2026. doi:10.1016/j.chembiol.2025.12.014
BibTeX
@article{Sebastio2026,
author = {Sebastião, Ana M},
title = {Adenosine signaling as a hub for the action of novel antidepressant strategies},
journal = {Cell Chemical Biology},
year = {2026},
doi = {10.1016/j.chembiol.2025.12.014}
}
EUVIMED